Studies Confirm Safety of 9-Valent HPV Vaccination
Studies based on searching Vaccine Adverse Event Reporting System, six Vaccine Safety Datalink sites.
Cervical Cancer
Cervical Cancer Screening Remains Low in Women Ages 45 to 65 Years
Screening rates are insufficient to reduce cervical cancer incidence.
Cervical Cancer Treatment Regimens
View a detailed drug treatment regimen chart for cervical cancer, including therapies such as cisplatin, cisplatin + 5-FU, and more.
Cancer Screening Rates Lower Among Women With Diabetes
Rates for breast, cervical, colorectal cancer screening lower compared with women without diabetes.
Brachytherapy Remains Important in Cervical Cancer Management
Despite widespread use of other forms of radiation therapy, consensus statements from SGO and ABS support the use of brachytherapy in the treatment of primary and recurrent cervical cancer.
Vaginal Moisture Eases Adverse Effects of Pulsed Dose Rate Brachytherapy for Cervical Cancer
A quasi-experimental study sought to determine if early vaginal moisturizing eases vaginal dryness and pain associated with PDR brachytherapy for cervical cancer.
Men Less Knowledgeable About HPV, HPV Vaccination
Most men and women did not know anal, penile, and oral cancers are caused by HPV.
Room for Improvement Found in HPV Vaccine Delivery Practices
Physicians not strongly recommending vaccine, not using presumptive style linked to refusal or deferral.
Psychologic Distress Linked to Cervical Cancer Mortality
Risk up with diagnosis of stress-related disorders or an occurrence of stressful life events around diagnosis.
One Dose of HPV Vaccine May Be Sufficient in Certain Situations
One dose compared with two or three doses in preventing cervical precancer in high-coverage settings.
Next post in Cervical Cancer
